Trial Profile
A Clinical Study for Inactivated Vaccine Against EV71
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Mar 2019
Price :
$35
*
At a glance
- Drugs Enterovirus A vaccine (Primary)
- Indications Enterovirus A infections
- Focus Adverse reactions
- Sponsors Medigen Vaccine Biologics; Medigen Vaccinology Corp
- 22 Feb 2019 Results assessing immunogenicity, safety, cross-reaction, and immune persistence of an inactivated enterovirus A71 vaccine, published in the Vaccine
- 15 Aug 2017 Status changed from active, no longer recruiting to completed.
- 22 Mar 2017 Planned primary completion date changed from 1 Feb 2017 to 1 May 2017.